Tricida (TCDA) Misses Q3 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. SPY
5. BA
6. STX
7. V
8. CSGP
9. LSTR
10. UPS

Go back to Tricida (TCDA) Misses Q3 EPS by 10c

Tricida Announces Third Quarter 2021 Financial Results

November 8, 2021 4:06 PM EST

Webcast Today at 4:30 pm Eastern Time

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic kidney disease (CKD) progression in patients with metabolic acidosis and CKD, announced today financial results for the three and nine months ended September 30, 2021 and provided an update on key initiatives.

Update on Key Initiatives:

Tricida continued to execute on... More